ELV Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-03-24 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 51,435 | S-Sale | D | 3,625 | 446.06 | 1,616,967.50 |
2023-03-24 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 55,060 | S-Sale | D | 5,573 | 445.30 | 2,481,656.90 |
2023-03-24 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 60,633 | S-Sale | D | 3,000 | 444.33 | 1,332,990.00 |
2023-03-24 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 63,633 | S-Sale | D | 1,800 | 443.27 | 797,886.00 |
2023-03-24 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 65,433 | S-Sale | D | 500 | 442.02 | 221,010.00 |
2023-03-24 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 65,933 | S-Sale | D | 600 | 440.78 | 264,468.00 |
2023-03-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 15,327 | S-Sale | D | 2,314 | 462.22 | 1,069,577.08 |
2023-03-02 | Penczek Ronald W | officer: CAO & Controller | 2,882 | F-InKind | D | 380 | 468.78 | 178,136.40 |
2023-03-02 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 17,641 | F-InKind | D | 1,084 | 468.78 | 508,157.52 |
2023-03-02 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 66,533 | F-InKind | D | 5,430 | 468.78 | 2,545,475.40 |
2023-03-02 | Norwood Felicia F | officer: EVP & President, GBD | 33,443 | F-InKind | D | 4,754 | 468.78 | 2,228,580.12 |
2023-03-02 | BOUDREAUX GAIL | director, officer: President and CEO | 135,863 | F-InKind | D | 17,614 | 468.78 | 8,257,090.92 |
2023-03-02 | Gallina John E | officer: EVP & Chief Financial Officer | 63,725 | F-InKind | D | 4,650 | 468.78 | 2,179,827.00 |
2023-03-02 | Haytaian Peter D | officer: EVP & Pres Carelon & CarelonRx | 17,893 | F-InKind | D | 5,469 | 468.78 | 2,563,757.82 |
2023-03-01 | Penczek Ronald W | officer: CAO & Controller | 819 | A-Award | D | 819 | 469.03 | 384,135.57 |
2023-03-01 | Penczek Ronald W | officer: CAO & Controller | 3,262 | A-Award | A | 1,195 | 0.00 | 0.00 |
2023-03-01 | Penczek Ronald W | officer: CAO & Controller | 2,067 | A-Award | A | 214 | 0.00 | 0.00 |
2023-03-01 | Penczek Ronald W | officer: CAO & Controller | 1,853 | F-InKind | D | 64 | 469.03 | 30,017.92 |
2023-03-01 | Todt Blair Williams | officer: EVP and Chief Legal Officer | 8,195 | A-Award | A | 8,195 | 469.03 | 3,843,700.85 |
2023-03-01 | Todt Blair Williams | officer: EVP and Chief Legal Officer | 12,628 | A-Award | A | 2,584 | 0.00 | 0.00 |
2023-03-01 | Todt Blair Williams | officer: EVP and Chief Legal Officer | 10,044 | A-Award | A | 2,133 | 0.00 | 0.00 |
2023-03-01 | Todt Blair Williams | officer: EVP and Chief Legal Officer | 7,911 | F-InKind | D | 372 | 469.03 | 174,479.16 |
2023-03-01 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 7,786 | A-Award | D | 7,786 | 469.03 | 3,651,867.58 |
2023-03-01 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 18,725 | A-Award | A | 2,542 | 0.00 | 0.00 |
2023-03-01 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 16,183 | A-Award | A | 2,026 | 0.00 | 0.00 |
2023-03-01 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 14,157 | F-InKind | D | 293 | 469.03 | 137,425.79 |
2023-03-01 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 8,195 | A-Award | D | 8,195 | 469.03 | 3,843,700.85 |
2023-03-01 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 71,963 | A-Award | A | 9,716 | 0.00 | 0.00 |
2023-03-01 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 62,247 | A-Award | A | 2,133 | 0.00 | 0.00 |
2023-03-01 | MCCARTHY GLORIA M | officer: EVP & Chief Administrative Off | 60,114 | F-InKind | D | 617 | 469.03 | 289,391.51 |
2023-03-01 | Norwood Felicia F | officer: EVP & President, GBD | 8,812 | A-Award | D | 8,812 | 469.03 | 4,133,092.36 |
2023-03-01 | Norwood Felicia F | officer: EVP & President, GBD | 38,197 | A-Award | A | 9,716 | 0.00 | 0.00 |
2023-03-01 | Norwood Felicia F | officer: EVP & President, GBD | 28,481 | A-Award | A | 2,292 | 0.00 | 0.00 |
2023-03-01 | Norwood Felicia F | officer: EVP & President, GBD | 26,189 | F-InKind | D | 495 | 469.03 | 232,169.85 |
2023-03-01 | BOUDREAUX GAIL | director, officer: President and CEO | 32,380 | A-Award | D | 32,380 | 469.03 | 15,187,191.40 |
2023-03-01 | BOUDREAUX GAIL | director, officer: President and CEO | 153,477 | A-Award | A | 35,875 | 0.00 | 0.00 |
2023-03-01 | BOUDREAUX GAIL | director, officer: President and CEO | 117,602 | A-Award | A | 8,422 | 0.00 | 0.00 |
2023-03-01 | BOUDREAUX GAIL | director, officer: President and CEO | 109,180 | F-InKind | D | 2,471 | 469.03 | 1,158,973.13 |
2023-03-01 | Gallina John E | officer: EVP & Chief Financial Officer | 11,782 | A-Award | D | 11,782 | 469.03 | 5,526,111.46 |
2023-03-01 | Gallina John E | officer: EVP & Chief Financial Officer | 68,375 | A-Award | A | 9,716 | 0.00 | 0.00 |
2023-03-01 | Gallina John E | officer: EVP & Chief Financial Officer | 58,659 | A-Award | A | 3,065 | 0.00 | 0.00 |
2023-03-01 | Gallina John E | officer: EVP & Chief Financial Officer | 55,594 | F-InKind | D | 587 | 469.03 | 275,320.61 |
2023-03-01 | Haytaian Peter D | officer: EVP & Pres Carelon & CarelonRx | 8,812 | A-Award | D | 8,812 | 469.03 | 4,133,092.36 |
2023-03-01 | Haytaian Peter D | officer: EVP & Pres Carelon & CarelonRx | 23,362 | A-Award | A | 9,716 | 0.00 | 0.00 |
2023-03-01 | Haytaian Peter D | officer: EVP & Pres Carelon & CarelonRx | 13,646 | A-Award | A | 2,292 | 0.00 | 0.00 |
2023-03-01 | Haytaian Peter D | officer: EVP & Pres Carelon & CarelonRx | 11,354 | F-InKind | D | 607 | 469.03 | 284,701.21 |
2023-01-03 | Todt Blair Williams | officer: EVP and Chief Legal Officer | 8,283 | A-Award | A | 3,983 | 0.00 | 0.00 |
2022-12-30 | Norwood Felicia F | officer: EVP & President, GBD | 26,684 | F-InKind | D | 1,754 | 512.97 | 899,749.38 |
2022-12-01 | Todt Blair Williams | officer: EVP and Chief Legal Officer | 4,300 | F-InKind | D | 117 | 525.25 | 61,454.25 |
2022-11-04 | BOUDREAUX GAIL | director, officer: President and CEO | 111,415 | G-Gift | D | 10,000 | 0.00 | 0.00 |
2022-11-01 | Haytaian Peter D | officer: EVP & Pres Carelon & IngenioRx | 11,961 | F-InKind | D | 200 | 544.53 | 108,906.00 |
2022-11-01 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 14,450 | F-InKind | D | 79 | 544.53 | 43,017.87 |
2022-11-01 | STRABLE-SOETHOUT DEANNA D | director | 200 | A-Award | A | 200 | 0.00 | 0.00 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 1,976 | M-Exempt | D | 987 | 311.48 | 307,430.76 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 1,387 | M-Exempt | D | 2,774 | 271.27 | 752,502.98 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 0 | M-Exempt | D | 568 | 232.04 | 131,798.72 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 14,529 | S-Sale | D | 206 | 491.39 | 101,226.34 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 14,735 | S-Sale | D | 522 | 490.83 | 256,213.26 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 15,257 | S-Sale | D | 784 | 489.49 | 383,760.16 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 16,041 | S-Sale | D | 2,616 | 488.64 | 1,278,282.24 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 18,657 | S-Sale | D | 2,200 | 487.45 | 1,072,390.00 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 20,857 | M-Exempt | A | 987 | 311.48 | 307,430.76 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 19,870 | M-Exempt | A | 568 | 232.04 | 131,798.72 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 19,302 | M-Exempt | A | 2,774 | 271.27 | 752,502.98 |
2022-06-09 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | 16,528 | M-Exempt | A | 1,999 | 307.68 | 615,052.32 |
2022-06-06 | Dixon Robert L JR | director | 9,491 | S-Sale | D | 420 | 497.14 | 208,798.80 |
2022-05-19 | PERU RAMIRO G | director | 9,405 | S-Sale | D | 990 | 468.88 | 464,191.20 |
2022-05-18 | Dixon Robert L JR | director | 9,911 | A-Award | A | 440 | 0.00 | 0.00 |
2022-05-18 | Jallal Bahija | director | 3,342 | A-Award | A | 440 | 0.00 | 0.00 |
2022-05-18 | Schneider Ryan M. | director | 5,154 | A-Award | A | 440 | 0.00 | 0.00 |
2022-05-18 | Tallett Elizabeth E | director | 9,446 | A-Award | A | 440 | 0.00 | 0.00 |
2022-05-18 | CLARK R KERRY | director | 8,194 | A-Award | A | 440 | 0.00 | 0.00 |
2022-05-18 | HAY LEWIS III | director | 10,061 | A-Award | A | 440 | 0.00 | 0.00 |
2022-05-18 | DeVore Susan D. | director | 856 | A-Award | A | 440 | 0.00 | 0.00 |
2022-05-18 | Neri Antonio F | director | 3,479 | A-Award | A | 440 | 0.00 | 0.00 |
2022-05-18 | PERU RAMIRO G | director | 10,395 | A-Award | A | 440 | 0.00 | 0.00 |
2022-03-10 | Haytaian Peter D | officer: EVP & Pres., DBG & IngenioRx | 0 | M-Exempt | D | 1,848 | 131.80 | 243,566.40 |
2022-03-10 | Haytaian Peter D | officer: EVP & Pres., DBG & IngenioRx | 12,161 | S-Sale | D | 40 | 463.40 | 18,536.00 |
2022-03-10 | Haytaian Peter D | officer: EVP & Pres., DBG & IngenioRx | 12,201 | S-Sale | D | 1,240 | 462.73 | 573,785.20 |
2022-03-10 | Haytaian Peter D | officer: EVP & Pres., DBG & IngenioRx | 13,441 | S-Sale | D | 5,874 | 461.72 | 2,712,143.28 |
2022-03-10 | Haytaian Peter D | officer: EVP & Pres., DBG & IngenioRx | 19,315 | S-Sale | D | 4,105 | 460.68 | 1,891,091.40 |
2022-03-10 | Haytaian Peter D | officer: EVP & Pres., DBG & IngenioRx | 23,420 | S-Sale | D | 4,274 | 459.75 | 1,964,971.50 |
2022-03-10 | Haytaian Peter D | officer: EVP & Pres., DBG & IngenioRx | 27,694 | S-Sale | D | 2,170 | 458.68 | 995,335.60 |
2022-03-10 | Haytaian Peter D | officer: EVP & Pres., DBG & IngenioRx | 29,864 | M-Exempt | A | 1,848 | 131.80 | 243,566.40 |
2022-03-03 | Penczek Ronald W | officer: CAO & Controller | 0 | M-Exempt | D | 468 | 307.68 | 143,994.24 |
2022-03-03 | Penczek Ronald W | officer: CAO & Controller | 654 | M-Exempt | D | 653 | 271.27 | 177,139.31 |
2022-03-03 | Penczek Ronald W | officer: CAO & Controller | 877 | M-Exempt | D | 438 | 311.48 | 136,428.24 |
2022-03-03 | Penczek Ronald W | officer: CAO & Controller | 1,902 | S-Sale | D | 2,423 | 463.68 | 1,123,496.64 |
2022-03-03 | Penczek Ronald W | officer: CAO & Controller | 4,325 | M-Exempt | A | 468 | 307.68 | 143,994.24 |
2022-03-03 | Penczek Ronald W | officer: CAO & Controller | 3,857 | M-Exempt | A | 653 | 271.27 | 177,139.31 |
2022-03-03 | Penczek Ronald W | officer: CAO & Controller | 3,204 | M-Exempt | A | 438 | 311.48 | 136,428.24 |
2022-03-02 | Penczek Ronald W | officer: CAO & Controller | 2,766 | F-InKind | D | 52 | 463.49 | 24,101.48 |
2022-03-01 | Penczek Ronald W | officer: CAO & Controller | 882 | A-Award | D | 882 | 451.50 | 398,223.00 |
2022-03-01 | Penczek Ronald W | officer: CAO & Controller | 2,818 | A-Award | A | 953 | 0.00 | 0.00 |
2022-03-01 | Penczek Ronald W | officer: CAO & Controller | 1,865 | A-Award | A | 222 | 0.00 | 0.00 |
2022-03-01 | Penczek Ronald W | officer: CAO & Controller | 1,643 | F-InKind | D | 369 | 451.50 | 166,603.50 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.